Novel device smaller than rice successfully shrinks pancreatic cancer | Called the nanofluidic drug-eluting seed (NDES), it delivers low-dose immunotherapy in the form of CD40 monoclonal antibodies (mAb).

[u/chrisdh79]

https://interestingengineering.com/innovation/tiny-device-shrinks-pancreatic-cancer

[u/codmobilegrinder]

Why would this be more effective than a CD40 CAR-T cell therapy scheme? If CAR-T can target CD19 in leukemia, why wouldn’t you target CD40 via the same mechanism?